We restore endothelial cell function.
Pantherna Therapeutics is a privately-held biopharmaceutical Company developing first-in-class therapeutics for vascular diseases. Pantherna’s innovative technology platform is based on advanced nanoparticles for the delivery and expression of therapeutic mRNA drugs in the endothelium.
Pantherna is based in Hennigsdorf (Brandenburg) close to Berlin, Germany.
Dr. Oliver Keil (CTO), Dr. Volker Fehring (Head of Formulation) and Dr. Klaus Giese (CEO) will attend the Creative Transformative Medicine Europe User Group Meeting to be held at the University of Strathclyde, Glasgow, on Wednesday, October 9, 2019. Dr. Klaus Giese will present Pantherna's delivery technology for mRNA therapeutics.
Get in touch
Pantherna Therapeutics GmbH
Telephone: +49(0)3302-202 240-0
Telefax: +49(0)3302-202 240-1
Managing Directors: Dr. Klaus Giese, Dr. Jörg Kaufmann, Dr. Gerrit Maass